Total Payments
$9,653
2024 Payments
$1,562
Companies
41
Transactions
441
Medicare Patients
1,617
Medicare Billing
$87,602
Payment Breakdown by Category
Food & Beverage$9,525 (98.7%)
Education$127.74 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,525 | 437 | 98.7% |
| Education | $127.74 | 4 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $1,231 | 58 | $0 (2020) |
| GlaxoSmithKline, LLC. | $1,213 | 52 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $974.69 | 44 | $0 (2024) |
| ABBVIE INC. | $962.87 | 54 | $0 (2024) |
| Novo Nordisk Inc | $931.87 | 44 | $0 (2024) |
| Allergan, Inc. | $521.47 | 18 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $407.86 | 25 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $369.89 | 14 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $356.14 | 15 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $347.16 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,562 | 73 | AstraZeneca Pharmaceuticals LP ($279.11) |
| 2023 | $1,694 | 69 | GlaxoSmithKline, LLC. ($252.32) |
| 2022 | $1,421 | 59 | GlaxoSmithKline, LLC. ($330.74) |
| 2021 | $1,524 | 66 | AbbVie Inc. ($385.49) |
| 2020 | $1,101 | 61 | Allergan, Inc. ($334.49) |
| 2019 | $1,528 | 77 | Gilead Sciences, Inc. ($785.05) |
| 2018 | $595.27 | 27 | Gilead Sciences, Inc. ($221.37) |
| 2017 | $227.13 | 9 | ViiV Healthcare Company ($90.00) |
All Payment Transactions
441 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Biological | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Biological | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Cardio-renal | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Biological | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: Biological | ||||||
| 09/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $115.78 | General |
| Category: Cardiovascular | ||||||
| 08/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Biological | ||||||
| 08/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 495 | 800 | $131,280 | $28,130 |
| 2022 | 8 | 502 | 828 | $129,920 | $25,276 |
| 2021 | 9 | 548 | 790 | $115,020 | $30,306 |
| 2020 | 3 | 72 | 94 | $9,916 | $3,891 |
Total Patients
1,617
Total Services
2,512
Medicare Billing
$87,602
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 265 | $72,875 | $10,800 | 14.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 75 | 75 | $21,000 | $4,225 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 77 | $14,630 | $3,391 | 23.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $7,920 | $3,390 | 42.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 118 | 249 | $4,980 | $2,092 | 42.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 27 | 27 | $3,645 | $1,939 | 53.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 40 | $2,200 | $1,282 | 58.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $715.00 | $416.65 | 58.3% |
| 92228 | Imaging of retina with remote review by physician | Office | 2023 | 24 | 25 | $2,125 | $414.12 | 19.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 17 | $1,190 | $180.75 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 250 | $72,125 | $11,905 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 122 | $23,770 | $5,040 | 21.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 61 | 61 | $18,340 | $3,187 | 17.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 31 | 31 | $4,185 | $2,125 | 50.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 44 | 44 | $2,420 | $1,382 | 57.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 130 | 282 | $6,340 | $830.23 | 13.1% |
| 92228 | Imaging of retina with remote review by physician | Office | 2022 | 25 | 25 | $2,125 | $427.57 | 20.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $615.00 | $379.16 | 61.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 140 | 229 | $68,700 | $14,810 | 21.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 36 | 36 | $11,340 | $5,082 | 44.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 89 | $17,800 | $3,589 | 20.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 48 | 48 | $2,835 | $2,646 | 93.3% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 14 | 14 | $2,940 | $1,745 | 59.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 60 | 60 | $2,100 | $1,092 | 52.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 151 | 279 | $6,975 | $825.11 | 11.8% |
About Aekata Shah
Aekata Shah is a Family Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2015. The National Provider Identifier (NPI) number assigned to this provider is 1972984458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Aekata Shah has received a total of $9,653 in payments from pharmaceutical and medical device companies, with $1,562 received in 2024. These payments were reported across 441 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($9,525).
As a Medicare-enrolled provider, Shah has provided services to 1,617 Medicare beneficiaries, totaling 2,512 services with total Medicare billing of $87,602. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Philadelphia, PA
- Active Since 06/10/2015
- Last Updated 10/21/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972984458
Products in Payments
- VRAYLAR (Drug) $1,115
- TRELEGY ELLIPTA (Drug) $1,074
- Ozempic (Drug) $553.77
- XIFAXAN (Drug) $411.68
- BREZTRI (Drug) $391.09
- Kerendia (Drug) $356.14
- JARDIANCE (Drug) $334.22
- FASENRA (Biological) $218.62
- Truvada (Drug) $218.55
- Descovy (Drug) $213.07
- Rybelsus (Drug) $210.70
- VYVANSE (Drug) $188.89
- SYMBICORT (Drug) $176.06
- ELIQUIS (Drug) $156.86
- MOUNJARO (Drug) $155.10
- FARXIGA (Drug) $146.67
- QULIPTA (Drug) $143.77
- Veozah (Drug) $141.98
- Trintellix (Drug) $129.28
- UBRELVY (Drug) $128.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Philadelphia
Dr. Michael Attanasio, D.o, D.O
Family Medicine — Payments: $263,805
Family Medicine $263,805
Dr. Deborah Witt, M.d, M.D
Family Medicine — Payments: $226,164
Family Medicine $226,164
Jonah Mink, Md, MD
Family Medicine — Payments: $146,427
Family Medicine $146,427
Celia Ezidiegwu, Md, MD
Family Medicine — Payments: $117,796
Family Medicine $117,796
Dr. Glenn Rosen, Md, MD
Family Medicine — Payments: $77,390
Family Medicine $77,390
Dr. Casey Lafferty, D.o, D.O
Family Medicine — Payments: $54,627
Family Medicine $54,627